AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Superko, H. R.
Right arrow Articles by Wood, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Superko, H. R.
Right arrow Articles by Wood, P. D.
Agricola
Right arrow Articles by Superko, H. R.
Right arrow Articles by Wood, P. D.

American Journal of Clinical Nutrition, Vol 54, 599-605, Copyright © 1991 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Caffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial

HR Superko, W Bortz Jr, PT Williams, JJ Albers and PD Wood
Stanford Center for Research in Disease Prevention, Stanford University School of Medicine, CA.

Coffee consumption has been associated with elevated plasma cholesterol. One hundred eighty-one men consumed a standard caffeinated coffee for 2 mo followed by randomization to continue caffeinated coffee (control), change to decaffeinated coffee or no coffee for 2 mo. Plasma low-density-lipoprotein (LDL) cholesterol and apolipoprotein B concentrations increased significantly (0.12 +/- 0.65 mmol/L, P less than 0.025; 0.06 +/- 0.12 g/L, P less than 0.0004, respectively) in the group that changed to decaffeinated coffee. In a subgroup (n = 51), post-heparin lipoprotein lipase decreased significantly more (-270 mmol free fatty acids.L-1.h-1, P less than 0.003) in the decaffeinated- coffee group. Resting heart rate and blood pressure did not change significantly. Change from caffeinated to decaffeinated coffee increased plasma LDL cholesterol and apolipoprotein B whereas discontinuation of caffeinated coffee revealed no change. This finding suggests that a coffee component other than caffeine is responsible for the LDL cholesterol, apolipoprotein B, and lipase activity changes reported in this investigation.


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
M. Namdar, P. Koepfli, R. Grathwohl, P. T. Siegrist, M. Klainguti, T. Schepis, R. Delaloye, C. A. Wyss, S. P. Fleischmann, O. Gaemperli, et al.
Caffeine Decreases Exercise-Induced Myocardial Flow Reserve
J. Am. Coll. Cardiol., January 17, 2006; 47(2): 405 - 410.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
S. H. Jee, J. He, L. J. Appel, P. K. Whelton, I. Suh, and M. J. Klag
Coffee Consumption and Serum Lipids: A Meta-Analysis of Randomized Controlled Clinical Trials
Am. J. Epidemiol., February 15, 2001; 153(4): 353 - 362.
[Abstract] [Full Text] [PDF]

Home page
 Arch Fam MedHome page
G. M. Etherton and M. S. Kochar
Coffee: Facts and Controversies
Arch Fam Med, March 1, 1993; 2(3): 317 - 322.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The American Society for Nutrition